Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Kidney & Renal Pelvis (Late Stage^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Percentlate
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 4.8 (4.7, 4.8) N/A 18,519 28.3
Puerto Rico 6 2.0 (1.8, 2.2) N/A 84 23.4
Alabama 6 4.4 (4.2, 4.7) 39 (25, 44) 275 24.6
Maryland 6 3.9 (3.7, 4.1) 47 (41, 49) 287 25.2
Delaware 6 4.1 (3.6, 4.6) 45 (24, 49) 54 25.3
Mississippi 6 5.4 (5.1, 5.8) 10 (2, 24) 199 25.3
Virginia 6 3.9 (3.8, 4.1) 46 (41, 49) 406 25.3
Arkansas 6 5.5 (5.1, 5.8) 9 (2, 24) 206 25.5
Tennessee 6 5.0 (4.8, 5.2) 24 (13, 29) 427 25.6
North Carolina 6 4.8 (4.6, 5.0) 26 (20, 35) 619 26.6
South Carolina 6 4.6 (4.3, 4.8) 34 (23, 43) 301 26.6
Idaho 3 4.7 (4.3, 5.1) 28 (14, 45) 97 26.8
Arizona 6 4.2 (4.0, 4.4) 43 (36, 47) 377 26.9
Kansas 6 5.2 (4.8, 5.5) 20 (5, 30) 179 26.9
Colorado 6 3.8 (3.6, 4.1) 48 (42, 49) 248 27.0
New York 3 4.6 (4.5, 4.7) 32 (24, 40) 1,113 27.5
Louisiana 3 6.2 (5.9, 6.5) 1 (1, 6) 346 27.6
Pennsylvania 6 4.6 (4.5, 4.8) 31 (24, 40) 788 27.6
New Hampshire 6 4.5 (4.0, 4.9) 37 (18, 48) 85 27.7
North Dakota 6 5.0 (4.3, 5.7) 25 (3, 46) 45 27.7
Florida 6 4.1 (4.0, 4.2) 44 (40, 47) 1,237 27.8
Texas 3 5.5 (5.4, 5.6) 8 (4, 16) 1,634 27.9
District of Columbia 6 3.2 (2.6, 3.9) 49 (42, 49) 23 28.0
Oklahoma 6 5.7 (5.3, 6.0) 5 (1, 19) 267 28.0
Utah 3 4.2 (3.9, 4.6) 42 (26, 48) 119 28.1
Montana 6 4.7 (4.2, 5.3) 27 (8, 46) 67 28.3
Oregon 6 4.3 (4.1, 4.6) 40 (26, 46) 234 28.3
Kentucky 3 5.8 (5.6, 6.1) 4 (1, 13) 326 28.4
Nebraska 6 5.1 (4.7, 5.5) 22 (5, 37) 116 28.4
Alaska 6 5.2 (4.5, 6.0) 19 (1, 44) 40 28.6
New Jersey 3 4.6 (4.4, 4.8) 33 (24, 41) 510 28.6
Michigan 6 4.6 (4.4, 4.8) 30 (23, 41) 594 28.9
Connecticut 3 4.5 (4.2, 4.8) 35 (22, 44) 210 29.1
West Virginia 6 5.9 (5.5, 6.4) 3 (1, 18) 150 29.3
Illinois 3 5.3 (5.1, 5.5) 13 (7, 23) 812 29.5
Massachusetts 3 4.5 (4.3, 4.7) 36 (24, 42) 389 29.5
Missouri 6 5.6 (5.4, 5.9) 6 (2, 17) 436 29.5
South Dakota 6 5.0 (4.4, 5.7) 23 (3, 43) 56 29.5
Georgia 3 5.2 (5.0, 5.4) 17 (9, 25) 617 29.9
Wisconsin 6 5.6 (5.3, 5.8) 7 (3, 19) 421 30.0
California 3 4.4 (4.3, 4.5) 38 (31, 42) 1,977 30.1
Ohio 6 5.2 (5.0, 5.4) 18 (10, 25) 777 30.3
Washington 5 4.6 (4.4, 4.8) 29 (23, 41) 414 30.4
Minnesota 6 5.3 (5.0, 5.6) 14 (5, 25) 363 30.5
Iowa 3 6.1 (5.7, 6.4) 2 (1, 9) 248 31.5
Maine 6 5.3 (4.8, 5.8) 16 (2, 32) 106 31.8
Hawaii 3 4.3 (3.8, 4.7) 41 (23, 48) 79 32.1
Rhode Island 6 5.4 (4.8, 6.0) 12 (1, 34) 73 32.8
Vermont 6 5.3 (4.6, 6.1) 15 (1, 41) 46 33.1
Wyoming 6 5.1 (4.4, 5.9) 21 (1, 45) 38 33.8
New Mexico 3 5.4 (5.0, 5.9) 11 (2, 26) 144 34.9
Indiana 6
data not available
N/A
data not available
data not available
Nevada 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 03/04/2024 5:34 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana, Nevada

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top